IgAN
American Society of Nephrology (ASN) 2023
Philadelphia, PA
November 1-5, 2023
Abstracts and Posters
Atacicept in IgAN: Continued Protective Titers to Diphtheria and Tetanus and Balanced Infections vs Placebo With a Focus on COVID-19
Barratt J, et al.
Atacicept Reduces Hematuria and Serum Gd-IgA1, Both Associated With Long-Term Renal Outcomes in IgAN: 36 Week Results From the Phase 2b ORIGIN Study
Barratt J, et al.
ORIGIN 3: Pivotal Ph3 Study Evaluating Effect of Atacicept vs. Placebo on Proteinuria and Renal Function Preservation in IgAN
Barratt J, et al.